Last reviewed · How we verify

NCT03775603

Comparison of TOFscan and TOF-Watch SX in Pediatric Neuromuscular Function Recovery

Completed Last updated 16 April 2020
What this trial tests

trial testing TOFscan in Neuromuscular Blockade in 37 participants. Completed in 30 January 2020.

Timeline
2 March 2019
Primary endpoint
9 January 2020
30 January 2020

Quick facts

Lead sponsorSeoul National University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment37
Start date2 March 2019
Primary completion9 January 2020
Estimated completion30 January 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Under 12, any sex, with Neuromuscular Blockade. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of TOFscan and TOF-Watch SX for monitoring of neuromuscular blockade function in children

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of the TOFscan and the TOF-Watch SX during pediatric neuromuscular function recovery: a prospective observational study.
    Yhim HB, Jang YE, Lee JH, Kim EH, et al · · 2021 · cited 6× · PMID 34886885 · DOI 10.1186/s13741-021-00215-2

Verify or expand the search:

Other trials of TOFscan

Trials testing the same drug.

Other recruiting trials for Neuromuscular Blockade

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03775603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing